alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32.1**

**Certification ofCEO and CFO Pursuant to18 U.S.C. Section 1350,as Adopted Pursuant toSection 906 of the Sarbanes-Oxley Act of 2002**

In connection withthe Quarterly Report on Form 10-Q of Cherokee InternationalCorporation (the “Company”) for the quarterly period ended July 2, 2006, asfiled with the Securities and Exchange Commission on the date hereof (the “Report”),Jeffrey M. Frank, as President, Chief Executive Officer, and Director of theCompany, and Linster W. Fox, as Executive Vice President, Chief FinancialOfficer, and Secretary of the Company, each hereby certifies, pursuant to 18U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that, to the best of his knowledge:

1.                 TheReport fully complies with the requirements of Section 13(a) or15(d) of the Securities Act of 1934; and

2.                 The informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.
| /s/  JEFFREY M. FRANK                 |                                            |
|---------------------------------------|-------------------------------------------------|
| Name:                                 | Jeffrey M. Frank                                |
| Title:                                | President, Chief Executive Officer and Director |
|                                  | (Principal Executive Officer)                   |
|                                  |                                            |
| Date:  August 16, 2006 |
|                                  |                                            |
| /s/ LINSTER W. FOX                    |                                            |
| Name:                                 | Linster W. Fox                                  |
| Title:                                | Executive Vice President,                       |
|                                  | Chief Financial Officer and Secretary           |
|                                  | (Principal Financial and Accounting Officer)    |
|                                  |
| Date:  August 16, 2006      |
|                                       |                                                 |  |

 

A signed original of this written statement requiredby Section 906 of the Sarbanes-Oxley Act of 2002 has been provided toCherokee International Corporation and will be retained by CherokeeInternational Corporation and furnished to the Securities and ExchangeCommission or its staff upon request.

----
Fourth Court of Appeals

San Antonio, Texas

JUDGMENT

No. 04-13-00576-CR

Cynthia AMBROSE,

Appellant

v.

The STATE of Texas,

Appellee

From the 226th Judicial District Court, Bexar County, Texas

Trial Court No. 2012CR10002

Honorable Sid L. Harle, Judge Presiding

BEFORE JUSTICE MARION, JUSTICE BARNARD, AND JUSTICE MARTINEZ

In accordance with this court’s opinion of this date, appellant’s Motion to Withdraw 

Appeal is GRANTED and this appeal is DISMISSED. 

SIGNED November 6, 2013.

_________________________________

Sandee Bryan Marion, Justice
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3468 Introduced in House (IH)]

<DOC>

117th CONGRESS
  1st Session
                                H. R. 3468

  To amend the CARES Act to expand a national awareness and outreach 
 campaign to address the importance and safety of plasma donation, and 
                          for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 21, 2021

  Mr. Peters (for himself and Mr. Wenstrup) introduced the following 
    bill; which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
  To amend the CARES Act to expand a national awareness and outreach 
 campaign to address the importance and safety of plasma donation, and 
                          for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Plasma Donation Awareness Act of 
2021''.

SEC. 2. IMPORTANCE OF THE BLOOD AND PLASMA SUPPLY.

    (a) In General.--Section 3226 of the CARES Act (Public Law 116-136) 
is amended--
            (1) in the section heading, by inserting ``and plasma'' 
        after ``blood''; and
            (2) by inserting after ``blood'' each time it appears ``and 
        plasma''.
    (b) Conforming Amendment.--The item relating to section 3226 in the 
table of contents in section 2 of the CARES Act (Public Law 116-136) is 
amended to read as follows:

``Sec. 3226. Importance of the blood and plasma supply.''.
                                 <all>
```
IB 

Union Calendar No. 376 

117TH CONGRESS 

2D SESSION H. R. 3460 

[Report No. 117–494] 

To amend title 28 of the United States Code to prevent the transfer of 

actions arising under the antitrust laws in which a State is a complainant. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 21, 2021 

Mr. BUCK (for himself, Mr. OWENS, Mr. CICILLINE, and Mr. BISHOP of 

North Carolina) introduced the following bill; which was referred to the 

Committee on the Judiciary 

SEPTEMBER 26, 2022 

Additional sponsors: Mr. NEGUSE, Mr. BILIRAKIS, Mr. NORMAN, Mr. ROY, 

Ms. HERRELL, Mr. GOSAR, Mr. ARMSTRONG, Mr. KHANNA, Mrs. 

BOEBERT, Mr. SCHWEIKERT, Mr. GOOD of Virginia, Mr. MOONEY, Mr. 

JOHNSON of Georgia, Mr. JONES, Mr. NADLER, Mr. BANKS, Mr. DEFAZIO, Mr. GOODEN of Texas, Mr. BUDD, Mr. CLOUD, Mr. ROSENDALE, 

Mr. CURTIS, Mr. VAN DREW, Mr. HICE of Georgia, Mr. JOHNSON of 

South Dakota, Mr. BURGESS, Mrs. HARTZLER, Mr. COLE, Mr. WEBER

of Texas, Ms. TENNEY, Mr. ROUZER, Mr. HILL, Mr. MEUSER, Mr. WILLIAMS of Texas, Mr. CLINE, Mr. KUSTOFF, and Mr. SMITH of Missouri 

SEPTEMBER 26, 2022 

Reported with amendments, committed to the Committee of the Whole House 

on the State of the Union, and ordered to be printed 

[Strike out all after the enacting clause and insert the part printed in italic] 

[For text of introduced bill, see copy of bill as introduced on May 21, 2021] 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•HR 3460 RH

A BILL 

To amend title 28 of the United States Code to prevent 

the transfer of actions arising under the antitrust laws 

in which a State is a complainant. 


pamtmann on DSKBC07HB2PROD with BILLS
3 

•HR 3460 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘State Antitrust Enforce5 ment Venue Act of 2022’’. 

6 SEC. 2. AMENDMENTS. 

7 Section 1407 of title 28 of the United States Code is 

8 amended— 

9 (1) in subsection (g) by inserting ‘‘or a State’’ 

10 after ‘‘United States’’, and 

11 (2) by striking subsection (h). 

12 SEC. 3. EFFECTIVE DATE. 

13 This Act and the amendments made by this Act, shall 

14 take effect on June 1, 2021. 

Amend the title so as to read: ‘‘A bill to promote 

competition by preventing the transfer of actions arising 

under the antitrust laws in which a State is a complainant.’’. 


pamtmann on DSKBC07HB2PROD with BILLS
Union Calendar No. 376 

117TH CONGRESS 

2D SESSION H. R. 3460 

[Report No. 117–494] 

A BILL 

To amend title 28 of the United States Code to 

antitrust laws in which a State is a complainant. prevent the transfer of actions arising under the 

SEPTEMBER 26, 2022 

Reported with amendments, committed to the Committee 

dered to be printed of the Whole House on the State of the Union, and orVerDate Sep 11 2014 21:15 Sep 26, 2022 Jkt 029200 PO 00000 Frm 00004 Fmt 6651 Sfmt 6651 E:\BILLS\H3460.RH H3460

pamtmann on DSKBC07HB2PROD with BILLS
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of OMNOVA Solutions Inc. (the Company) on Form 10-Q for the quarter ended February 28, 2009
as filed with the Securities and Exchange Commission on the date hereof (the Report), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to such officers knowledge:



| | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the
periods expressed in the Report.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                     |  |  |  |                       |  |                                                  
|-------------------- |  |  |  | --------------------- |  | -------------------------------------------------
|Date: March 25, 2009 |  |  |  | /s/ Kevin M. McMullen
|                     |  |  |  | Name:                 |  | Kevin M. McMullen                                
|                     |  |  |  | Title:                |  | Chairman, Chief Executive Officer and President  
|                     |  | 
|                     |  |  |  | /s/ Michael E. Hicks 
|                     |  |  |  | Name:                 |  | Michael E. Hicks                                 
|                     |  |  |  | Title:                |  | Senior Vice President and Chief Financial Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and
is not being filed as part of the Report or as a separate disclosure document.
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                         0000803058
<NAME>                        TOTAL RESEARCH CORPORATION
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S. Dollars

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                             JUN-30-2000
<PERIOD-START>                                JUL-01-1999
<PERIOD-END>                                  JUN-30-2000
<EXCHANGE-RATE>                                        1
<CASH>                                         6,711,882
<SECURITIES>                                           0
<RECEIVABLES>                                 10,556,045
<ALLOWANCES>                                     182,340
<INVENTORY>                                            0
<CURRENT-ASSETS>                              23,088,975
<PP&E>                                         9,834,264
<DEPRECIATION>                                 5,575,904
<TOTAL-ASSETS>                                35,119,187
<CURRENT-LIABILITIES>                         19,023,901
<BONDS>                                                0
<PREFERRED-MANDATORY>                                  0
<PREFERRED>                                            0
<COMMON>                                          12,615
<OTHER-SE>                                    11,892,848
<TOTAL-LIABILITY-AND-EQUITY>                  35,119,187
<SALES>                                       50,755,769
<TOTAL-REVENUES>                              50,755,769
<CGS>                                         25,028,136
<TOTAL-COSTS>                                 47,767,058
<OTHER-EXPENSES>                                  34,775
<LOSS-PROVISION>                                       0
<INTEREST-EXPENSE>                              (152,128)
<INCOME-PRETAX>                                3,106,064
<INCOME-TAX>                                   1,189,436
<INCOME-CONTINUING>                            1,916,628
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   1,916,628
<EPS-BASIC>                                        .16
<EPS-DILUTED>                                        .14


</TABLE>
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3285 Referred in Senate (RFS)]

<DOC>
117th CONGRESS
  2d Session
                                H. R. 3285

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             June 22, 2022

  Received; read twice and referred to the Committee on the Judiciary

_______________________________________________________________________

                                 AN ACT

 
 To amend gendered terms in Federal law relating to the President and 
                        the President's spouse.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``21st Century President Act''.

SEC. 2. MODERNIZATION OF TERMS RELATING TO THE PRESIDENT AND THE SPOUSE 
              OF A PRESIDENT.

    Section 879(b)(1)(A) of title 18, United States Code, is amended by 
striking ``the wife of a former President during his lifetime, the 
widow of a former President until her death or remarriage'' and 
inserting ``the spouse of a former President during a former 
President's lifetime, the surviving spouse of a former President until 
the surviving spouse's death or remarriage''.

            Passed the House of Representatives June 21, 2022.

            Attest:

                                             CHERYL L. JOHNSON,

                                                                 Clerk.

                               By Kevin McCumber,

                                                          Deputy Clerk.
```
{"version":"1.0","provider_name":"Federal Mediation and Conciliation Service","provider_url":"https:\/\/www.fmcs.gov","title":"FMCS Observes Conflict Resolution Day 2015 - Federal Mediation and Conciliation Service","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"EqmTReg84s\"><a href=\"https:\/\/www.fmcs.gov\/fmcs-observes-conflict-resolution-day-2015\/\">FMCS Observes Conflict Resolution Day 2015<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.fmcs.gov\/fmcs-observes-conflict-resolution-day-2015\/embed\/#?secret=EqmTReg84s\" width=\"600\" height=\"338\" title=\"“FMCS Observes Conflict Resolution Day 2015” — Federal Mediation and Conciliation Service\" data-secret=\"EqmTReg84s\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","description":"FMCS joins other Federal agencies and organizations around the world in observance of Conflict Resolution Day."}
<PAGE>
                                                                    EXHIBIT 23.1
 
               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
 
    We consent to the incorporation by reference in the Registration Statements
(Form S-8 File Nos. 33-11703, 33-16529, 33-18717, 33-26003, 33-34919, 33-38536,
33-40879, 33-44305, 33-44333, 33-48890, 33-59098, 33-65190, 33-50999, 33-51275,
33-58017, 33-60213, 33-60215, 333-01211, 333-06403, 333-08651 and 333-15977)
pertaining to the Employee Stock Purchase Plan, 1987 Stock Option Plan, 1986
Incentive Stock Option Plan, 1985 Stock Incentive Program, 1984 Incentive Stock
Option Plan, 1982 Stock Option Plan, Directors' Stock Option Plan and Subsidiary
Stock Agreement, 1993 Long-Term Incentive Stock Plan and the 1996 Supplemental
Non-Executive Equity Incentive Plan of Silicon Graphics, Inc.; the 1990 Stock
Option Plan of Wavefront Technologies, Inc.; and the 1988 Employee Share
Ownership Plan, 1989 Employee Share Ownership Plan, 1990 Employee Share
Ownership Plan, and the 1994 Stock Plan of Alias Research Inc. and the Amended
and Restated 1989 Employee Benefit Stock Plan, and 1989 Non-Employee Directors'
Stock Option Plan of Cray Research, Inc. of our reports dated July 18, 1997 with
respect to the consolidated financial statements and schedule of Silicon
Graphics, Inc. included in this Annual Report (Form 10-K) for the year ended
June 30, 1997.
 
                                                           /s/ Ernst & Young LLP
 
Palo Alto, California
September 26, 1997
Exhibit 32.2
 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002
  (1)
    
    the Report fully complies with the requirements of Section 13(a) or 15 (d) of the Securities
Exchange Act of 1934, as amended; and(2)
    
    the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
 Date: October 27, 2009
    By:
    /s/ Fernando L. FernandezFERNANDO L. FERNANDEZSenior Vice President  Finance, Chief Financial
Officer, Treasurer and Secretary
exv10w53



 





Exhibit 10.53




AMENDMENT NO. 1 TO

MANUFACTURE AND SUPPLY AGREEMENT

BETWEEN BIO-RAD LABORATORIES, INC.

AND

CIPHERGEN BIOSYSTEMS, INC.



This AMENDMENT NO. 1 (this “Amendment”), dated August 27, 2007 (the “Effective Date”), amends the
Manufacture and Supply Agreement between BIO-RAD LABORATORIES, INC. (“BIO-RAD”) and CIPHERGEN
BIOSYSTEMS, INC. (“CIPHERGEN”), dated November 13, 2006 (the “Agreement”). The parties hereby agree
as follows:





	1.	 	All terms used in this Amendment shall have the meaning given such terms in the Agreement
unless otherwise defined herein.
	 
	2.	 	Wherever the name “CIPHERGEN BIOSYSTEMS, INC.” appears in the Agreement, the name
“VERMILLION, INC.” shall be substituted therefor, and wherever the name “CIPHERGEN” appears
in the Agreement, the name “VERMILLION” shall be substituted therefor.
	 
	3.	 	Section 1.9 of the Agreement is hereby modified to read as follows:






	 	“1.9	 	“Manufacturing Information” shall mean the following
information with respect to the PRODUCTS: (a) instrument prototypes, if
available; (b) manufacturing drawings and specifications, including any
applicable schematics; (c) manufacturing drawings and specifications covering
any special tooling and the operation thereof; (d) manufacturing methods and
procedures; (e) manufacturing records; (f) technical know-how; (g) a detailed
list of all commercially available parts, components and software purchased or
licensed on the open market, disclosing the part number, name and location of
the supplier(s) and applicable software licenses; if any; (h) with respect to
consumable items, a detailed list of all commercially available ingredients,
specifications for making ingredients that are not commercially available and
tools for producing such consumables; (i) repair specifications and test
procedures for instruments and any component parts thereof including, without
limitation, installation, operation and performance qualifications as
available; (j) source code for any software licensed for use in conjunction
with instruments; (k) patent applications and patents owned or licensed
applicable to the manufacture of PRODUCTS; (l) software licenses; (m) quality
control, testing and quality assurance




 









 






	 	 	 	procedures, (n) material safety data sheets; and (o) all protocols relating
to PRODUCTS including, without limitation, protocols for the manufacture,
operation and use of PRODUCTS.”






	3.	 	Except as expressly modified by this Amendment, all of the terms and conditions of the
Agreement shall remain in full force and effect.





     IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their
respective authorized representatives.



	 	 	 	 	 	 	 	 	 	 	 
	VERMILLION, INC.	 	 	 	BIO-RAD LABORATORIES, INC.	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ William C. Sullivan
	 	 	 	By:
	 	/s/ Sanford S. Wadler	 	 
	Name:

	 	 

William C. Sullivan
	 	 
	 	Name:
	 	 

Sanford S. Wadler
	 	 
	Its:

	 	Vice President of Corporate Operations
	 	 	 	Its:
	 	Vice President & General Counsel	 	 
	Date:

	 	9/11/07
	 	 	 	Date:
	 	8/29/07	 	 







2